Objectives: HIV prevention strategies including pre- exposure prophylaxis (PrEP) must reach all in need to achieve elimination of transmission by 2030. Mainstream provision may inadvertently exclude key populations. Incidence of HIV in people who inject drugs (PWID) in Glasgow, Scotland's largest city, is increasing, partly due to sexual transmission. Scotland provides publicly funded oral PrEP for individuals at sexual risk of HIV through sexual health services; however, uptake by PWID has been negligible. We developed a tailored outreach PrEP service based in the local homeless health centre. We used active case finding, flexibility of assessment location, supervised community daily dispensing and active follow- up to optimise uptake and ...
BackgroundAntiretroviral pre-exposure prophylaxis (PrEP) is clinically efficacious and recommended f...
Introduction: Once-daily tenofovir/emtricitabine-based pre-exposure prophylaxis (PrEP) can reduce HI...
BACKGROUND AND AIMS: Pre-exposure prophylaxis for HIV, or 'PrEP', is the use of antiretroviral medic...
BackgroundHIV pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV acquisition. To ...
IntroductionHIV pre-exposure prophylaxis (PrEP), in which people take HIV medication to prevent HIV ...
OBJECTIVES: Pre-exposure prophylaxis (PrEP) has proven biological efficacy in reducing the risk of s...
Abstract Background The New South Wales (NSW) HIV Strategy 2016–2020 aims for the virtual eliminatio...
Background: Pre-exposure prophylaxis (PrEP) is an evidence-based new biomedical HIV prevention inter...
Objectives: To explore the acceptability of pre-exposure prophylaxis (PrEP) among gay, bisexual and ...
Background: There is an ongoing HIV outbreak amongst people who inject drugs (PWID) in Glasgow, Scot...
Background: Nearly 30 years after the initial cases of human immunodeficiency virus in the United St...
Worldwide HIV rates have slowly been decreasing, except among men who have sex with men, where unfor...
Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV...
Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV...
ObjectivesIdentifying prescribing strategies that improve the efficiency of PrEP should increase its...
BackgroundAntiretroviral pre-exposure prophylaxis (PrEP) is clinically efficacious and recommended f...
Introduction: Once-daily tenofovir/emtricitabine-based pre-exposure prophylaxis (PrEP) can reduce HI...
BACKGROUND AND AIMS: Pre-exposure prophylaxis for HIV, or 'PrEP', is the use of antiretroviral medic...
BackgroundHIV pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV acquisition. To ...
IntroductionHIV pre-exposure prophylaxis (PrEP), in which people take HIV medication to prevent HIV ...
OBJECTIVES: Pre-exposure prophylaxis (PrEP) has proven biological efficacy in reducing the risk of s...
Abstract Background The New South Wales (NSW) HIV Strategy 2016–2020 aims for the virtual eliminatio...
Background: Pre-exposure prophylaxis (PrEP) is an evidence-based new biomedical HIV prevention inter...
Objectives: To explore the acceptability of pre-exposure prophylaxis (PrEP) among gay, bisexual and ...
Background: There is an ongoing HIV outbreak amongst people who inject drugs (PWID) in Glasgow, Scot...
Background: Nearly 30 years after the initial cases of human immunodeficiency virus in the United St...
Worldwide HIV rates have slowly been decreasing, except among men who have sex with men, where unfor...
Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV...
Background: Pre-exposure prophylaxis (PrEP) is the use of HIV anti-retroviral therapy to prevent HIV...
ObjectivesIdentifying prescribing strategies that improve the efficiency of PrEP should increase its...
BackgroundAntiretroviral pre-exposure prophylaxis (PrEP) is clinically efficacious and recommended f...
Introduction: Once-daily tenofovir/emtricitabine-based pre-exposure prophylaxis (PrEP) can reduce HI...
BACKGROUND AND AIMS: Pre-exposure prophylaxis for HIV, or 'PrEP', is the use of antiretroviral medic...